AKT1 and cancer: We further found that PcrV-mediated TAM reprogramming potentiated their NO-mediated cytotoxicity against cancer cells, effects that were exerted through the activation of a PI3K/AKT/mTOR-glycolysis-NO feedback loop via direct interaction with TLR4.